Bibliografía del artículo
1. Hayashi A, Doi O, Azuma I, Toyoshima K. Immunofriendly use of BCG-cell wall skeleton remarkably improves the survival rate of various cancer patients. Proc Japan Acad 1998; 74(B):50-58.
2. Akazawa T, Masuda H, Saeki Y, Matsumoto M, Takeda K, Akira S, Azuma I, Toyoshima K, Seya T. Adjuvant-mediated tumor regression and tumor-specific CTL induction are impaired in MyD88-deficient mice. Cancer Res 2004; 64:757-764.
3. Honda K, Sakaguchi S, Nakajima C, Watanabe A, Yanai H, Matsumoto M, Ohteki T, Kaisho T, Takaoka A, Akira S, Seya T, Taniguchi T. Selective contribution of IFN- signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infectin. Proc Natl Acad Sci USA 2003; 100:10872-10877.
4. Matsuo-Tanabe M, Kawamoto T, Tanida S, Matsumoto M, Seya T. Toll-like receptor 2 agonists with unique properties synthesized with reference to a product of Streptosporangium. Immunology 2004 pp. 235-241.
5. Uehori J, Tsuji S, Matsumoto M, Kawata C, Takeuchi T, Akira S, Azuma I, Toyoshima K, Seya T. Simultaneous blocking of human Toll-like receptor 2 and 4 suppresses myeloid dendritic cell maturation induced by Mycobacterium bovis bacillus Calmette-Guérin (BCG)-peptidoglycan (PGN). Infect Immun 2003; 71:4238-4249.
6. Masuda H, Akazawa T, Ebihara T, Hazeki K, Matsumoto M, Seya T. Anti-tumor natural killer cell activation induced by spirulina extract. Cancer Science (submitted).
7. Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T. Activation of the human innate immune system by spirulina: Augmentation of interferon gamma production and NK cytotoxicity by oral administration of spirulina. Int Immunopharmacology 2002; 2:423-434.
8. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A, Toyoshima K, Seya T. Maturation of human human dendritic cells by cell-wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin: involvement of Toll-like receptors. Infect Immun 2000; 68:6883-6890.
9. Seya T, Akazawa T, Matsumoto M, Begum NA, Azuma I, Toyoshima K. Innate immune therapy for cancer: application of BCG-CWS and spirulina to patients with lung cancer. Anticancer Res 2003; 23:4369-4376.
10. Seya T, Akazawa T, Tsujita T, Matsumoto M. Application of Toll-like receptor agonists to vaccine adjuvant therapy. eCAM Feb issue (review) 2006.